{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T14:55:17Z","timestamp":1763477717143,"version":"3.40.5"},"reference-count":63,"publisher":"King Faisal Specialist Hospital and Research Centre","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Saudi Med"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>In December 2019, a novel coronavirus was identified in patients in Wuhan, China. The virus, subsequently named severe acute respiratory syndrome coronavirus-2, spread worldwide and the disease (coronavirus disease 2019 or COVID-19) was declared a global pandemic by the World Health Organization in March 2020. Older adults and individuals with comorbidities have been reported as being more vulnerable to COVID-19. Patients with chronic liver disease (CLD) have compromised immune function due to cirrhosis and are more susceptible to infection. However, it is unclear if patients with CLD are more vulnerable to COVID-19 and its complications than other populations. The high number of severe cases of COVID-19 has placed an unusual burden on health systems, compromising their capacity to provide the regular care that patients with CLD require. Hence, it is incredibly crucial at this juncture to provide a set of interim recommendations on the management of patients with CLD during the current COVID-19 outbreak.<\/jats:p>","DOI":"10.5144\/0256-4947.2020.273","type":"journal-article","created":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T07:30:28Z","timestamp":1592724628000},"page":"273-280","source":"Crossref","is-referenced-by-count":11,"title":["Principles of Care for Patients with Liver Disease During the Coronavirus Disease 2019 (COVID-19) Pandemic: Position Statement of the Saudi Association for the Study of Liver Disease and Transplantation"],"prefix":"10.5144","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2017-3526","authenticated-orcid":true,"given":"Saleh A.","family":"Alqahtani","sequence":"first","affiliation":[{"name":"From the Liver Transplant Unit, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"},{"name":"From the Division of Gastroenterology and Hepatology, Johns Hopkins University, Baltimore, Maryland, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulrahman A.","family":"Aljumah","sequence":"additional","affiliation":[{"name":"From the College of Medicine, Dar Al Uloom University, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Almoutaz","family":"Hashim","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, University of Jeddah, Jeddah, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thamer H.","family":"Alenazi","sequence":"additional","affiliation":[{"name":"From the College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia"},{"name":"From the Infectious Disease Division, King Abdulaziz Medical City, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"AlJawad","sequence":"additional","affiliation":[{"name":"From the Multi-organ Transplant Center, King Fahad Specialist Hospital, Dammam. Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleed K.","family":"Al Hamoudi","sequence":"additional","affiliation":[{"name":"From the Liver Research Center, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Y.","family":"Alghamdi","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, King Fahd Military Medical Complex, Dhahran, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3134","reference":[{"doi-asserted-by":"publisher","key":"e_1_3_1_2_2","DOI":"10.1080\/22221751.2020.1719902"},{"doi-asserted-by":"publisher","key":"e_1_3_1_3_2","DOI":"10.1038\/s41564-020-0695-z"},{"doi-asserted-by":"publisher","key":"e_1_3_1_4_2","DOI":"10.1038\/s41586-020-2012-7"},{"doi-asserted-by":"publisher","key":"e_1_3_1_5_2","DOI":"10.1056\/NEJMe2001126"},{"doi-asserted-by":"publisher","key":"e_1_3_1_6_2","DOI":"10.1016\/s0140-6736(20)30251-8"},{"doi-asserted-by":"publisher","key":"e_1_3_1_7_2","DOI":"10.1001\/JAMA.2020.4683"},{"unstructured":"Worldometer. https:\/\/www.worldometers.info\/coronavirus\/coronavirus-death-rate\/#comparison [","key":"e_1_3_1_8_2"},{"unstructured":"Hewings-Martin Y. How do SARS and MERS compare with COVID-19? : Medical News Today; 2020 [updated 10 Apr 2020. Available from: https:\/\/www.medicalnews-today.com\/articles\/how-do-sars-and-mers-compare-with-covid-19 accessed 09 May 2020 2020.","key":"e_1_3_1_9_2"},{"doi-asserted-by":"publisher","key":"e_1_3_1_10_2","DOI":"10.1093\/cid\/ciaa272"},{"doi-asserted-by":"publisher","key":"e_1_3_1_11_2","DOI":"10.1001\/JAMA.2020.2648"},{"doi-asserted-by":"publisher","key":"e_1_3_1_12_2","DOI":"10.1016\/j.jhepr.2020.100113"},{"doi-asserted-by":"publisher","key":"e_1_3_1_13_2","DOI":"10.1183\/13993003.00547-2020"},{"doi-asserted-by":"publisher","key":"e_1_3_1_14_2","DOI":"10.1056\/NEJMoa2002032"},{"doi-asserted-by":"publisher","key":"e_1_3_1_15_2","DOI":"10.1016\/s0140-6736(20)30183-5"},{"doi-asserted-by":"publisher","key":"e_1_3_1_16_2","DOI":"10.1111\/liv.14435"},{"doi-asserted-by":"publisher","key":"e_1_3_1_17_2","DOI":"10.1016\/j.cell.2020.02.058"},{"doi-asserted-by":"publisher","key":"e_1_3_1_18_2","DOI":"10.1136\/gut.2004.062398"},{"doi-asserted-by":"publisher","key":"e_1_3_1_19_2","DOI":"10.1002\/path.1570"},{"doi-asserted-by":"publisher","key":"e_1_3_1_20_2","DOI":"10.1101\/2020.02.03.931766"},{"doi-asserted-by":"publisher","key":"e_1_3_1_21_2","DOI":"10.1002\/path.1560"},{"doi-asserted-by":"publisher","key":"e_1_3_1_22_2","DOI":"10.1086\/426870"},{"doi-asserted-by":"publisher","key":"e_1_3_1_23_2","DOI":"10.1001\/archinte.160.1.113"},{"doi-asserted-by":"publisher","key":"e_1_3_1_24_2","DOI":"10.1016\/j.jhep.2014.08.010"},{"doi-asserted-by":"publisher","key":"e_1_3_1_25_2","DOI":"10.1086\/318501"},{"doi-asserted-by":"publisher","key":"e_1_3_1_26_2","DOI":"10.4254\/wjh.v8.i6.307"},{"doi-asserted-by":"publisher","key":"e_1_3_1_27_2","DOI":"10.1016\/s0140-6736(20)30628-0"},{"unstructured":"Secure-Cirrhosis Registry. Surveillance Epidemiology of Coronavirus (COVID-19) Under Research Exclusion 2020 [Available from: https:\/\/covidcirrhosis.web.unc.edu\/ accessed April 16 2020.","key":"e_1_3_1_28_2"},{"unstructured":"COVID-Hep. 2020 [Available from: https:\/\/covid-hep.net\/.","key":"e_1_3_1_29_2"},{"doi-asserted-by":"publisher","key":"e_1_3_1_30_2","DOI":"10.1097\/meg.0000000000001191"},{"doi-asserted-by":"publisher","key":"e_1_3_1_31_2","DOI":"10.1007\/s00392-020-01626-9"},{"doi-asserted-by":"publisher","key":"e_1_3_1_32_2","DOI":"10.20524\/aog.2019.0429"},{"doi-asserted-by":"publisher","key":"e_1_3_1_33_2","DOI":"10.1101\/2020.03.30.20048058"},{"doi-asserted-by":"publisher","key":"e_1_3_1_34_2","DOI":"10.1002\/jmv.25801"},{"doi-asserted-by":"publisher","key":"e_1_3_1_35_2","DOI":"10.1016\/j.jhep.2020.04.002"},{"doi-asserted-by":"publisher","key":"e_1_3_1_36_2","DOI":"10.1053\/j.gastro.2020.03.072"},{"doi-asserted-by":"publisher","key":"e_1_3_1_37_2","DOI":"10.1111\/irv.12735"},{"doi-asserted-by":"publisher","key":"e_1_3_1_38_2","DOI":"10.1001\/JAMA.2020.6019"},{"unstructured":"IDSA. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 2020 [Available from: https:\/\/www.idsociety.org\/practice-guideline\/covid-19-guideline-treatment-and-management\/.","key":"e_1_3_1_39_2"},{"unstructured":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury 2017 [Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548832\/ accessed April 16 2020.","key":"e_1_3_1_40_2"},{"unstructured":"Group LDI. HEP Drug Interactions [Available from: https:\/\/www.hep-druginteractions.org\/ accessed April 16 2020.","key":"e_1_3_1_41_2"},{"unstructured":"Kujawski SA Wong KK Collins JP et al. First 12 patients with coronavirus disease 2019 (COVID-19) in the United States. medRxiv 2020:2020.03.09.20032896 [Preprint]. 2020. Available from: https:\/\/www.medrxiv.org\/content\/10.1101\/2020.03.09.20032896v1 [accessed 2020 Apr 18].","key":"e_1_3_1_42_2"},{"unstructured":"Detailed recommendations for interactions with experimental COVID-19 therapies (Liverpool Drug Interaction Group 2020) Available from: https:\/\/www.covid19-druginteractions.org\/. [accessed 2020 Apr 18].","key":"e_1_3_1_43_2"},{"doi-asserted-by":"publisher","key":"e_1_3_1_44_2","DOI":"10.1056\/NEJMoa2007016"},{"issue":"12","key":"e_1_3_1_45_2","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1128\/AAC.42.12.3218","article-title":"ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease","volume":"42","author":"Sham HL","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"e_1_3_1_46_2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1310\/hct1205-235","article-title":"Safety and pharmacokinetics of lopinavir in HIV\/HCV coinfected patients with advanced liver disease","volume":"12","author":"Casado JL","year":"2011","journal-title":"HIV Clin Trials"},{"issue":"19","key":"e_1_3_1_47_2","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19","volume":"382","author":"Cao B","year":"2020","journal-title":"N Engl J Med"},{"issue":"10223","key":"e_1_3_1_48_2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen N","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"e_1_3_1_49_2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier E","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"e_1_3_1_50_2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu J","year":"2020","journal-title":"Cell Discov"},{"key":"e_1_3_1_51_2","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret P","year":"2020","journal-title":"Int J Anti-microb Agents"},{"issue":"3","key":"e_1_3_1_52_2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.dsx.2020.03.011","article-title":"Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries","volume":"14","author":"Singh AK","year":"2020","journal-title":"Diabetes Metab Syndr"},{"doi-asserted-by":"crossref","unstructured":"Chen Z Hu J Zhang Z et al. Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial. medRxiv 2020:2020.03.22.20040758 [Pre-print]. 2020. Available from: https:\/\/www.medrxiv.org\/content\/10.1101\/2020.03.22.20040758v3 [accessed 2020 Apr 18].","key":"e_1_3_1_53_2","DOI":"10.1101\/2020.03.22.20040758"},{"issue":"7","key":"e_1_3_1_54_2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2183\/pjab.93.027","article-title":"Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase","volume":"93","author":"Furuta Y","year":"2017","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"unstructured":"Chen C Huang J Yin P et al. Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial. medRxiv 2020:2020.03.17.20037432 [Preprint]. 2020. Available from: https:\/\/www.medrxiv.org\/content\/10.1101\/2020.03.17.20037432v4 [accessed 2020 Apr 18].","key":"e_1_3_1_55_2"},{"issue":"1","key":"e_1_3_1_56_2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","article-title":"The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights","volume":"335","author":"Coutinho AE","year":"2011","journal-title":"Mol Cell Endocrinol"},{"unstructured":"Clinical management of severe acute respiratory infection when novel coronavirus infection is suspected (WHO 2020). Available from: https:\/\/www.who.int\/publications-detail\/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected [accessed 2020 Apr 18].","key":"e_1_3_1_57_2"},{"issue":"10223","key":"e_1_3_1_58_2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","volume":"395","author":"Russell CD","year":"2020","journal-title":"Lancet"},{"issue":"10223","key":"e_1_3_1_59_2","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","volume":"395","author":"Richardson P","year":"2020","journal-title":"Lancet"},{"key":"e_1_3_1_60_2","doi-asserted-by":"crossref","first-page":"105967","DOI":"10.1016\/j.ijantimicag.2020.105967","article-title":"Baricitinib - A Janus Kinase Inhibitor - Not An Ideal Option For Management of COVID-19","author":"Praveen D","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"e_1_3_1_61_2","doi-asserted-by":"crossref","first-page":"e001095","DOI":"10.1136\/rmdopen-2019-001095","article-title":"Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis","volume":"6","author":"Harigai M","year":"2020","journal-title":"RMD Open"},{"doi-asserted-by":"publisher","key":"e_1_3_1_62_2","DOI":"10.1016\/j.ijantimicag.2020.105982"},{"doi-asserted-by":"publisher","key":"e_1_3_1_63_2","DOI":"10.1002\/jmv.25801"},{"unstructured":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Tocilizumab. [Updated 2015 Jun 18]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548243\/","key":"e_1_3_1_64_2"}],"container-title":["Annals of Saudi Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T18:03:55Z","timestamp":1696269835000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.annsaudimed.net\/doi\/10.5144\/0256-4947.2020.273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.5144\/0256-4947.2020.273"],"URL":"https:\/\/doi.org\/10.5144\/0256-4947.2020.273","relation":{},"ISSN":["0256-4947","0975-4466"],"issn-type":[{"type":"print","value":"0256-4947"},{"type":"electronic","value":"0975-4466"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}